FDA's moringa investigation is not a wellness argument. It is a shelf check.

The agency's outbreak page ties moringa leaf powder to an ongoing Salmonella investigation and tells consumers not to eat, sell, or serve recalled products. It also gives the unglamorous second step that recall coverage often loses: wash and sanitize surfaces and containers that may have touched the powder. [1]

Total Nutrition expanded its recall on June 3 to include TNVitamins Ultra Potent Complete Green Superfood Moringa 10,000 mg and Doctor's Pride Complete Green Superfood Ultra Potent Moringa 10,000 mg, adding lot 2748 and naming online sales channels. [2] Mogo Moringa separately recalled select Moringa capsules, with lots 15525AA and 00926AA named in the FDA notice. [3] The point is not that all supplements are suspect. The point is that product name, brand, form, and lot number now matter more than the word moringa.

This is where X has little to offer a household. The research path found no verified status post that cleanly carried the recall details. FDA, by contrast, gives a task sequence: identify the product, check the lot, stop use, discard or return as instructed, and clean the shelf. [1]

The service journalism is almost embarrassingly domestic. Open the cabinet. Pull out the green-powder jars and capsules. Compare the label with the FDA pages. Do not taste-test anything. Do not pour it into a smoothie because it looks normal. Salmonella is not visible, and recall lot numbers are not vibes.

The larger story is familiar. Supplements are sold as intimate objects, private acts of self-improvement. Recalls make them public objects again: manufactured, distributed, tracked, and sometimes investigated. A reader does not need a theory of wellness to act on that. She needs a label, a trash bag, hot water, and the patience to clean the spoon drawer.

-- NORA WHITFIELD, Chicago